| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +1.8% |
| R&D Expense | $35.4M | +183.8% |
| SG&A Expense | $13.5M | +105.9% |
| Operating Income | -$47.8M | -166.4% |
| Pre-tax Income | -$47.8M | -166.3% |
| Income Tax | $3K | +30.8% |
| Net Income | -$47.8M | -166.3% |
| EPS (Basic) | -$0.25 | +49.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.1M | -33.9% |
| Current Assets | $71.0M | -31.8% |
| Total Assets | $74.6M | -31.1% |
| Current Liabilities | $5.8M | +37.6% |
| Total Liabilities | $9.9M | -39.1% |
| Stockholders' Equity | $64.7M | -29.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.3M | -274.8% |
| Capital Expenditures | $200K | -27.2% |
| Investing Cash Flow | -$200K | +27.2% |
| Financing Cash Flow | $10.5M | -90.8% |
| Free Cash Flow | -$45.5M | -268.1% |